Skip to main content
Clinical Trials/NCT06589336
NCT06589336
Completed
Not Applicable

SUSTAIN: Promoting Sustained Behavior Change and Nutrition Security in Medicaid-Enrolled Individuals With Stage 2 Cardiovascular-Kidney-Metabolic Syndrome (CKMS)

Ohio State University1 site in 1 country106 target enrollmentStarted: August 26, 2024Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
106
Locations
1
Primary Endpoint
Enrollment

Overview

Brief Summary

To determine the feasibility and engagement of participants in the SUSTAIN intervention compared to enhanced usual care over 24 weeks through mixed-methods measurement of participant enrollment, adherence, retention, and engagement (counseling, screenings, referrals, and uptake). Methods: Leveraging rigorous quantitative and qualitative evaluation, the study team will identify mechanisms driving intervention feasibility and engagement. Hypothesis: SUSTAIN will be feasible with a high degree of engagement among Medicaid-enrolled participants with Stage 2 CKMS in comparison to enhanced usual care.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients must be Medicaid enrolled, and/or dual enrolled in Medicaid
  • Patients must be diagnosed with at least one of the following diseases: hypertension, type 2 diabetes mellitus, hyperlipidemia, chronic kidney disease and/or metabolic syndrome
  • Patients must at least 18 years of age or older at the time of signing consent
  • Patient must have access to internet-enabled device
  • Patient has no objections to online grocery shopping, home food deliveries, or nutrition counseling
  • Patient lives in setting able to receive Instacart deliveries (e.g., non-institutionalized)
  • Patient is willing to use a credit card for Instacart back-up payments

Exclusion Criteria

  • Have any condition that impacts digestion, metabolism, or food intake (e.g., surgical loss of esophagus, stomach, or colon, pancreatic dysfunction, bariatric surgery, brain surgery that alters cognition, etc.)
  • Have active digestive illnesses (i.e., Celiac disease, irritable bowel syndrome, chronic malabsorption)
  • Any comorbidity such as psychiatric or general illness that may put the subject at risk as determined by investigator
  • Any other factor which, in the investigator's opinion, is likely to compromise the subject's ability to participate in the study
  • Recent (e.g., 6 months) participation in other behavioral nutrition trials
  • Are currently pregnant or are planning to become pregnant during the study

Outcomes

Primary Outcomes

Enrollment

Time Frame: Week 1

Enrollment will be determined by the percent of eligible participants who enroll in the study.

Adherence - Mid-Ohio Farmacy

Time Frame: 24 weeks

Adherence will be determined based on the number of visits to food pantries divided by the total number of possible visits.

Adherence - Health Impact Ohio

Time Frame: 24 weeks

Adherence to the Health Impact Ohio component of the intervention to address social needs will be determined based on the percent of participants that enroll with the community health worker.

Adherence - Behavioral Nutritional Counseling

Time Frame: 16 weeks

Adherence to behavioral nutritional counseling will be determined by the number of interactions with behavioral counseling out of the total number of counseling sessions offered.

Retention

Time Frame: 24 weeks

The percent of participants that complete the study visits at 12 and 24 weeks.

Engagement

Time Frame: 8 weeks

Engagement will be determined by the amount of total dollars spent on Instacart per participant.

Secondary Outcomes

  • Nutrition Security(24 weeks)
  • Dietary Patterns(24 weeks)
  • Cardiometabolic Health(24 weeks)
  • Purchasing Behavior(24 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Joshua Joseph, MD

Principal Investigator

Ohio State University

Study Sites (1)

Loading locations...

Similar Trials